Publs. oficiales Innate Pharma

Acciones

Mercado cerrado - Euronext Paris Otros sitios de cotización 17:35:23 14/05/2024			Varia. Cinco días.	Varia. 1 de enero.
2,325 ^EUR	+1,09 %		+1,53 %	-11,26 %

15/04	Innate Pharma anuncia que el activador de células NK SAR443579 / IPH6101, desarrollado por Sanofi, avanza a la fase 2 para pacientes con cáncer de sangre	CI
10/04	Innate Pharma S.A. presenta en AACR 2024 la eficacia preclínica de su candidato a fármaco pre-IND IPH45, un novedoso conjugado anticuerpo-fármaco contra la Nectina-4	CI

Threshold crossings	21/10/22	CO
Provisional calendar	20/10/22	CO
Provisional calendar	20/10/22	CO
Slide show half-year results	15/09/22	CO
1st-half-year results	15/09/22	CO
1st-half-year results	15/09/22	CO
Half-year report	15/09/22	CO
Half-year report	15/09/22	CO
Monthly statement on voting rights	31/07/22	CO
Monthly statement on voting rights	31/07/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	28/07/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	28/07/22	CO
Threshold crossings	18/07/22	CO
Corporate officers' Statement : Sale	29/06/22	CO
Corporate officers' Statement : Sale	17/06/22	CO
Corporate officers' Statement : Sale	14/06/22	CO
Corporate officers' Statement : Sale	14/06/22	CO
Corporate officers' Statement : Sale	14/06/22	CO
Slide show Q1	10/05/22	CO
1st quarter turnover	10/05/22	CO
1st quarter turnover	10/05/22	CO
Monthly statement on voting rights	30/04/22	CO
Monthly statement on voting rights	30/04/22	CO
Monthly statement on voting rights	28/02/22	CO
Monthly statement on voting rights	28/02/22	CO